Blue Fin Capital, Inc. Novartis Ag Transaction History

Blue Fin Capital, Inc.

$529 Million
Q4 2024

A detailed history of Blue Fin Capital, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Blue Fin Capital, Inc. holds 2,200 shares of NVS stock, worth $239,910. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,200

Previous 2,220 0.9%

Holding current value

$239,910

Previous $255,000 16.08%

% of portfolio

0.04%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 18, 2025	SELL	$96.78 - $117.18 $1,935 - $2,343	-20 Reduced 0.9%	2,200 $214,000
Q3 2024 Nov 05, 2024	SELL	$106.13 - $120.89 $11,568 - $13,177	-109 Reduced 4.68%	2,220 $255,000
Q2 2024 Jul 30, 2024	BUY	$92.57 - $107.37 $833 - $966	9 Added 0.39%	2,329 $247,000
Q1 2024 May 14, 2024	SELL	$95.27 - $108.47 $95 - $108	-1 Reduced 0.04%	2,320 $224,000
Q3 2023 Oct 19, 2023	SELL	$94.73 - $105.13 $4,073 - $4,520	-43 Reduced 1.82%	2,321 $236,000
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $8,083 - $9,373	-101 Reduced 4.1%	2,364 $217,000
Q4 2022 Jan 23, 2023	BUY	$75.55 - $92.52 $186,230 - $228,061	2,465 New	2,465 $0
Q1 2022 Apr 12, 2022	BUY	$80.11 - $90.62 $720 - $815	9 Added 0.35%	2,564 $225,000
Q4 2021 Jan 19, 2022	SELL	$79.7 - $88.13 $72,447 - $80,110	-909 Reduced 26.24%	2,555 $223,000
Q3 2021 Oct 25, 2021	SELL	$81.78 - $95.14 $78,263 - $91,048	-957 Reduced 21.65%	3,464 $283,000
Q2 2021 Jul 19, 2021	SELL	$85.24 - $94.15 $40,489 - $44,721	-475 Reduced 9.7%	4,421 $403,000
Q1 2021 May 05, 2021	SELL	$83.5 - $98.47 $20,791 - $24,519	-249 Reduced 4.84%	4,896 $418,000
Q4 2020 Jan 28, 2021	BUY	$78.07 - $94.43 $113,123 - $136,829	1,449 Added 39.2%	5,145 $485,000
Q2 2020 Aug 10, 2020	BUY	$80.93 - $91.1 $11,411 - $12,845	141 Added 3.97%	3,696 $322,000
Q1 2020 Apr 28, 2020	SELL	$70.67 - $99.01 $14,770 - $20,693	-209 Reduced 5.55%	3,555 $293,000
Q4 2019 Feb 10, 2020	SELL	$84.35 - $95.37 $6,326 - $7,152	-75 Reduced 1.95%	3,764 $355,000
Q3 2019 Nov 07, 2019	SELL	$85.54 - $94.26 $4,448 - $4,901	-52 Reduced 1.34%	3,839 $333,000
Q1 2019 Apr 23, 2019	BUY	$75.32 - $86.15 $6,025 - $6,892	80 Added 2.1%	3,891 $374,000
Q4 2018 Jan 16, 2019	SELL	$73.66 - $82.02 $41,691 - $46,423	-566 Reduced 12.93%	3,811 $327,000
Q2 2018 Aug 06, 2018	SELL	$64.91 - $73.36 $19,732 - $22,301	-304 Reduced 6.49%	4,377 $331,000
Q1 2018 May 07, 2018	BUY	$70.39 - $84.15 $31,675 - $37,867	450 Added 10.64%	4,681 $378,000
Q4 2017 Jan 26, 2018	SELL	$72.33 - $77.64 $31,246 - $33,540	-432 Reduced 9.26%	4,231 $355,000
Q3 2017 Oct 11, 2017	BUY	$74.14 - $77.27 $345,714 - $360,310	4,663	4,663 $400,000

Others Institutions Holding NVS

# of Institutions

1,477

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $235B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Fin Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Blue Fin Capital, Inc. with notifications on news.

Account

Blue Fin Capital, Inc. Novartis Ag Transaction History